Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.59 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.59 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 10/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.40 |
| ▸ | GRM6 | O15303 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24645944 | 0.88 | NOD1 (0.53) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL16057141 | 0.87 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL5463061 | 0.86 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL1332934 | 0.86 | PTGS1 (0.61) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL316091 | 0.85 | PTGS1 (0.60) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL19549046 | 0.85 | PTGS1 (0.60) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL928710 | 0.85 | PTGS1 (0.59) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL1296494 | 0.85 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL236404 | 0.85 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 | |
| SCHEMBL8591691 | 0.85 | PTGS1 (0.56) | PTGS1GSTK1GLO1NOD1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1853292-B1 | PHARMACEUTICAL COMPOSITION COMPRISING GLUTATHIONE COMPOUNDS AND BETALAIN FOR THE PREVENTION AND TREATMENT OF CANCER | GERNOT TREUSCH (ES) | 2008-12-10 | — | — | EP | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | disclosed |
| EP-4440342-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2024-10-09 | — | — | EP | disclosed |
| WO-2023102149-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2023-06-08 | — | — | WO | disclosed |
| US-20220208386-A1 | DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-06-30 | — | — | US | disclosed |
| CN-114008045-A | Agrohorticultural agent containing novel imidazopyridine-2-carboxamide derivative as active ingredient | 阿格罗－金正株式会社 | 2022-02-01 | — | — | CN | disclosed |
| CN-113227373-A | Control of coleopteran insects | 绿光生物科技股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
| US-10231958-B2 | Methods and compositions for enhancing chemotherapy | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-03-19 | — | — | US | disclosed |
| WO-2018211450-A1 | COMPOSITION AND METHODS FOR INHIBITION OF METAL CORROSION FOR USE IN THE OIL AND GAS INDUSTRY | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2018-11-22 | — | — | WO | disclosed |
| US-20170326120-A1 | METHODS AND COMPOSITIONS FOR ENHANCING CHEMOTHERAPY | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2017-11-16 | — | — | US | disclosed |
| EP-2398500-A2 | GLUTATHIONE-BASED DRUG DELIVERY SYSTEM | TO-BBB Holding B.V. (NL) | 2011-12-28 | — | — | EP | disclosed |
| WO-2010095940-A2 | GLUTATHIONE-BASED DRUG DELIVERY SYSTEM | TO-BBB HOLDING B.V. (NL) | 2010-08-26 | — | — | WO | disclosed |
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | UNIVERSITY OF DURHAM (GB) | 2010-07-22 | — | — | US | disclosed |
| EP-1853292-B1 | PHARMACEUTICAL COMPOSITION COMPRISING GLUTATHIONE COMPOUNDS AND BETALAIN FOR THE PREVENTION AND TREATMENT OF CANCER | GERNOT TREUSCH (ES) | 2008-12-10 | — | — | EP | disclosed |
| EP-1853292-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER | Gernot, Treusch (ES) | 2007-11-14 | — | — | EP | disclosed |
| WO-2006084768-A1 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER | GERNOT TREUSCH (ES) | 2006-08-17 | — | — | WO | disclosed |
| US-6242244-B1 | Microbial system for formaldehyde sensing and remediation | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2001-06-05 | — | — | US | disclosed |
| US-5837481-A | DETECTING FORMALDEHYDE IN WASTE SAMPLING, USING A RHODOBACTER SPHAEROIDES BACTERIAL CELL COMPRISING A GENETIC ENGINEERED LINKED GENE ENCODING A PROTEIN ENZYME TO DETECT, GENERATING A SIGNAL, BIOREMEDIATING, DETOXIFICATION | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1998-11-17 | — | — | US | disclosed |
| US-5834300-A | DETOXIFICATION BY BIOREMEDIATION; DETECTING THE FORMALDEHYDE IN A SAMPLE BY A PROTEIN, OXIDIZING THE FORMALDEHYDE BY DEHYDROGENASE PROTEIN, BOTH PROTEINS ARE CODED FROM A GENETIC ENGINEERED GENE | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1998-11-10 | — | — | US | disclosed |
| US-5747328-A | GENETIC ENGINEERING | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1998-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100184601-A1 | Method and Means Relating to Multiple Herbicide Resistance in Plants | GSTO1, GSTP1, GSR | PTGS1 830/4885GSTK1 9/4885GLO1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.